Variant Summary
- Also known as
- LYS111ASN,RS1057519934
- HGVS
- NM_006218.3:c.333G>C,NP_006209.2:p.Lys111Asn,NC_000003.11:g.178916946G>C,ENST00000263967.3:c.333G>C
- Variant Type(s)
- missense_variant
- Evidence Items
- 6
Evidence Level Distribution
Level D: 6
Evidence Items
Showing CIViC evidence rows where gene = PIK3CA and variant = K111N.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Her2-receptor Positive Breast Cancer | Pictilisib | 4 |
| D | Predictive | Does Not Support | Resistance | Her2-receptor Positive Breast Cancer | Trastuzumab Emtansine | 3 |
| D | Predictive | Does Not Support | Resistance | Her2-receptor Positive Breast Cancer | Trastuzumab,Dactolisib,Lapatinib | 2 |
| D | Predictive | Does Not Support | Resistance | Her2-receptor Positive Breast Cancer | Trastuzumab | 2 |
| D | Predictive | Supports | Sensitivity/Response | Her2-receptor Positive Breast Cancer | PI-103 | 1 |
| D | Predictive | Supports | Sensitivity/Response | Her2-receptor Positive Breast Cancer | PI3Ka/Di | 1 |